全文获取类型
收费全文 | 13768篇 |
免费 | 1169篇 |
国内免费 | 42篇 |
专业分类
耳鼻咽喉 | 96篇 |
儿科学 | 436篇 |
妇产科学 | 409篇 |
基础医学 | 1752篇 |
口腔科学 | 330篇 |
临床医学 | 1447篇 |
内科学 | 2753篇 |
皮肤病学 | 118篇 |
神经病学 | 1463篇 |
特种医学 | 541篇 |
外科学 | 1932篇 |
综合类 | 314篇 |
一般理论 | 26篇 |
预防医学 | 1398篇 |
眼科学 | 266篇 |
药学 | 852篇 |
2篇 | |
中国医学 | 39篇 |
肿瘤学 | 805篇 |
出版年
2021年 | 133篇 |
2020年 | 92篇 |
2019年 | 150篇 |
2018年 | 153篇 |
2017年 | 124篇 |
2016年 | 140篇 |
2015年 | 193篇 |
2014年 | 239篇 |
2013年 | 456篇 |
2012年 | 581篇 |
2011年 | 681篇 |
2010年 | 380篇 |
2009年 | 373篇 |
2008年 | 656篇 |
2007年 | 718篇 |
2006年 | 754篇 |
2005年 | 739篇 |
2004年 | 740篇 |
2003年 | 726篇 |
2002年 | 739篇 |
2001年 | 226篇 |
2000年 | 241篇 |
1999年 | 287篇 |
1998年 | 224篇 |
1997年 | 195篇 |
1996年 | 176篇 |
1995年 | 182篇 |
1994年 | 140篇 |
1993年 | 154篇 |
1992年 | 247篇 |
1991年 | 209篇 |
1990年 | 181篇 |
1989年 | 196篇 |
1988年 | 213篇 |
1987年 | 191篇 |
1986年 | 181篇 |
1985年 | 188篇 |
1984年 | 197篇 |
1983年 | 147篇 |
1982年 | 172篇 |
1981年 | 158篇 |
1980年 | 143篇 |
1979年 | 149篇 |
1978年 | 147篇 |
1977年 | 122篇 |
1976年 | 92篇 |
1975年 | 108篇 |
1974年 | 111篇 |
1973年 | 100篇 |
1972年 | 80篇 |
排序方式: 共有10000条查询结果,搜索用时 31 毫秒
91.
92.
Abrams DI Bebchuk JD Denning ET Davey RT Fox L Lane HC Sampson J Verheggen R Zeh D Markowitz NP;Terry Beirn Community Programs for Clinical Research on AIDS 《Journal of acquired immune deficiency syndromes (1999)》2002,29(3):221-231
The effect of intermittent courses of recombinant interleukin-2 (rIL-2) on HIV-1 load in patients receiving combination antiretroviral therapy remains uncertain. CPCRA 059 was an open-label, randomized, multicenter trial in which 511 patients with HIV-1 infection and CD4+ cell counts of > or = 300/mm3 who were receiving antiretroviral therapy were assigned to receive no rIL-2 (255 patients [controls]) or subcutaneous rIL-2 in dosages of 4.5 MIU (130) or 7.5 MIU (126) twice daily for 5-day courses every 8 weeks to maintain CD4+ cell counts that were twice the baseline value or > or = 1,000/mm3. The primary objective of this study was to compare the effects of the two doses of rIL-2 and no rIL-2 on viral load and CD4+ cell counts over 12 months. There was no difference in the following viral load measurements between the rIL-2 treatment groups and the control treatment group: percentage of patients with viral loads of <50 copies/mL at 12 months (p =.55), time to viral load of > or = 50 copies/mL for patients who had baseline viral loads of <50 copies/mL (p =.35), and change in viral load from baseline for patients who had viral loads of > or = 50 copies/mL at baseline (p =.63). At each follow-up visit, the change in CD4+ cell count from baseline was significantly greater in the rIL-2 treatment groups than in the control treatment group, with a mean difference of 251/mm3 at month 12 (95% confidence interval, 207-295; p <.0001). No unanticipated adverse experiences were seen in this trial, to our knowledge the largest randomized evaluation of rIL-2 treatment conducted to date. 相似文献
93.
94.
Incidence and determinants of moderate COPD (GOLD II) in male smokers aged 40–65 years: 5-year follow up
下载免费PDF全文
![点击此处可从《The British journal of general practice》网站下载免费的PDF全文](/ch/ext_images/free.gif)
Roeland MM Geijer Alfred PE Sachs Theo JM Verheij Philippe L Salom Jan-Willem J Lammers Arno W Hoes 《The British journal of general practice》2006,56(530):656-661
BACKGROUND: Chronic obstructive pulmonary disease (COPD) is a major health problem with an estimated prevalence of 10-15% among smokers. The incidence of moderate COPD, as defined by the Global Initiative for Chronic Obstructive Lung Disease (GOLD), is largely unknown. AIM: To determine the cumulative incidence of moderate COPD (forced expiratory volume in 1 second/forced vital capacity ratio [FEV1/FVC] <0.7 and FEV1 <80% predicted) and its association with patient characteristics in a cohort of male smokers. DESIGN: Prospective cohort study. SETTING: The city of IJsselstein, a small town in the Netherlands. METHOD: Smokers aged 40-65 years who were registered with local GPs, participated in a study to identify undetected COPD. Baseline measurements were taken in 1998 of 399 smokers with normal spirometry (n = 292) or mild COPD (FEV1/FVC <0.7 and FEV1 >or=80% predicted, n = 107) and follow-up measurements were conducted in 2003. RESULTS: After a mean follow-up of 5.2 years, 33 participants developed moderate COPD (GOLD II). This showed an estimated cumulative incidence of 8.3% (95% CI = 5.8 to 11.4) and a mean annual incidence of 1.6%. No participant developed severe airflow obstruction. The risk of developing moderate COPD in smokers with baseline mild COPD (GOLD I) was five times higher than in those with baseline normal spirometry (one in five versus one in 25). CONCLUSIONS: In a cohort of middle-aged male smokers, the estimated cumulative incidence of moderate COPD (GOLD II) over 5 years was relatively high (8.3%). Age, childhood smoking, cough, and one or more GP contacts for lower respiratory tract problems were independently associated with incident moderate COPD. 相似文献
95.
96.
McNeilly MD Robinson EL Anderson NB Pieper CF Shah A Toth PS Martin P Jackson D Saulter TD White C Kuchibatla M Collado SM Gerin W 《International journal of behavioral medicine》1995,2(4):321-338
It has been speculated that exposure to the chronic stress of racism contributes to the high rates of hypertension among African Americans. Social support may buffer the effects of stress on cardiovascular (CV) health by attenuating stress-induced CV responses that have been linked to hypertension. In this study we investigated the effects of racism and social support on CV reactivity in African American women. Participants showed greater increases in CV and emotional responses while responding and listening to racist provocation. Augmented blood pressure (BP) persisted through recovery following racial stress. Participants receiving no support showed the greatest increases in anger during racist provocation. No significant effects were seen for support on CV reactivity. These results provide some of the first evidence that interactive confrontation with racism elicits significant increases in CV reactivity and emotional distress. Furthermore, individuals receiving less support may be at greater risk for the potentially health-damaging effects of racial stress. These findings may have significant implications for the health of African Americans. 相似文献
97.
Granulocyte-macrophage colony-stimulating factor: presence in human follicular fluid, protein secretion and mRNA expression by ovarian cells 总被引:2,自引:0,他引:2
98.
99.
100.
While some salicylates (salicyclic acid and salicylaldehyde, especially) are as potent as aspirin as acute, orally-active anti-inflammatory drugs in the rat, they are either inactive or far less potent as PG synthesis inhibitors when added directly to isolated platelets or when given orally.Although PGE1 and PGE2 produce anti-ulcerogenic effects when given to rats in the presence of selected nonsteroidal anti-inflammatory drugs, they fail to inhibit the acute anti-inflammatory and anti-nociceptive effects of these drugs. They are anti-inflammatory and anti-nociceptive under certain experimental conditions. PGE1 and PGE2 can also behave as hypothermic agents when given subcutaneously. Related studies, using PG synthesis stimulators in vivo and in vitro (substituted phenylureas), also cause anti-nociception and hypothermia.All of these indirect studies, when taken together, infer that PG synthesis inhibitionper se fails to explain, entirely, the pharmacologic effects of non-steroidal anti-inflammatory drugs. They also suggest that the precise role of certain PGs in toxicopharmacology is far from simple and straightforward. 相似文献